Pr. Hsueh et al., FLAVOBACTERIUM INDOLOGENES BACTEREMIA - CLINICAL AND MICROBIOLOGICAL CHARACTERISTICS, Clinical infectious diseases, 23(3), 1996, pp. 550-555
To our knowledge, Flavobacterium indologenes has never been reported a
s a cause of bacteremia in humans. F. indologenes bacteremia was diagn
osed in 12 patients at a tertiary referral center in southern Taiwan b
etween 1 January 1992 and 31 December 1994. Six of these patients had
ventilator-associated pneumonia, two had primary bacteremia, and one p
atient each had pyonephrosis, peritonitis, biliary tract infection, an
d surgical wound infection. Five patients (42%) had malignancies, and
three (25%) had multiple burns. Polymicrobial bacteremia was diagnosed
in eight patients (67%). Two (17%) of the patients in this study died
; both had polymicrobial bacteremia. Antimicrobial susceptibility test
ing of the blood isolates from the 12 patients showed that >90% of the
isolates were susceptible to piperacillin, cefoperazone, ceftazidime,
and minocycline. The chromatograms of esterified fatty acids for the
isolates were identical. F. indologenes should be considered an etiolo
gic agent of bloodstream infection, especially in hospitalized patient
s with severe underlying diseases.